Fundz

Chromai secures tens of millions of RMB in Series A+ funding led by Ninebot Medical to enhance domestic production of ultra-high-performance liquid chromatography systems.

PRIVATEFeb 24, 2026

Amount Raised

¥10 Million

Round Type

Series A

ChinaManufacturingBiotechnology

Investors

Ninebot Medical

Description

Chromai has completed a strategic financing of tens of millions of RMB, exclusively invested by Ninebot Medical. The funds will be used to expand operations, accelerate market layout, and promote independent production. Founded in 2019, Chromai focuses on R&D and industrialization of high-end liquid chromatography products. Its UHPLC systems are applied in fields like biomedicine and environmental monitoring.

Quick answer

Chromai (Beijing) Technology Ltd raised ¥10 Million in a Series A round, dated February 24, 2026. Investors: Ninebot Medical. Chromai (Beijing) Technology Ltd is based in China.

How much did Chromai (Beijing) Technology Ltd raise?
Chromai (Beijing) Technology Ltd raised ¥10 Million in a Series A round on February 24, 2026.
Who invested in Chromai (Beijing) Technology Ltd?
Ninebot Medical is named as investors in this round.
What does Chromai (Beijing) Technology Ltd do?
Chromai (Beijing) Technology Co., Ltd. focuses on the R&D and industrialization of high-end liquid chromatography products.
Where is Chromai (Beijing) Technology Ltd based and how big is it?
Chromai (Beijing) Technology Ltd is based in China.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Chromai (Beijing) Technology Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Route 92 Medical raised $50M (Funding Round) on April 7, 2026.
  • PanTera raised $4M on March 31, 2026.
  • Neion Bio raised $11M (Seed) on March 27, 2026.
  • Cellbricks Therapeutics raised $8.1M (Seed) on March 26, 2026.
  • Elmed Life Sciences raised $2.7M (Seed) on March 26, 2026.
  • Circle8 Group Inc raised $5.6M (Post-IPO Equity) on March 26, 2026.

Who to call at Chromai (Beijing) Technology Ltd, and when

A new round usually means Chromai (Beijing) Technology Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Chromai (Beijing) Technology Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Chromai (Beijing) Technology Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Chromai (Beijing) Technology Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Chromai (Beijing) Technology Ltd

Location

China

About

Chromai (Beijing) Technology Co., Ltd. focuses on the R&D and industrialization of high-end liquid chromatography products. Established in 2019, it has achieved full independent R&D of ultra-high-performance liquid chromatography systems. Their innovative solutions have applications in biomedicine, food testing, environmental monitoring, and chemical materials. Chromai is at the forefront of domestic manufacturers aiming to break through technological barriers in this sector.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Chromai (Beijing) Technology Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Chromai (Beijing) Technology Ltd's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Chromai (Beijing) Technology Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.